Story perspectives

Rising Psychedelic Retreats Raise Safety Concerns Amid Lack of Standards

4/21/2026

Summary

Story summary

Interest in psychedelic retreats is growing, with many offering drug-assisted experiences.
However, these retreats often lack industry standards and regulations, raising safety concerns.
Experts warn that inadequate screening for medical conditions could pose risks for those with mental illnesses.
Many retreats recommend participants stop taking medications, which can be dangerous without supervision.
The FDA has not approved any psychedelics for treatment, while U.S. President Donald Trump has directed expedited reviews.

1 of 1

Story summary

Interest in psychedelic retreats is growing, with many offering drug-assisted experiences.
However, these retreats often lack industry standards and regulations, raising safety concerns.
Experts warn that inadequate screening for medical conditions could pose risks for those with mental illnesses.
Many retreats recommend participants stop taking medications, which can be dangerous without supervision.
The FDA has not approved any psychedelics for treatment, while U.S. President Donald Trump has directed expedited reviews.